Research Paper Volume 15, Issue 24 pp 15025—15049

The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis

class="figure-viewer-img"

Figure 1. Overall survival of NSCLC patients treated with ICIs based on age group in the cBio database. HR, hazard ratio.